NASDAQ: CRDF
Cardiff Oncology Inc Stock Ownership - Who owns Cardiff Oncology?

Insider buying vs selling

Have Cardiff Oncology Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Gary W. PaceDirector2025-07-30275,000$2.45
$673.75kBuy
Gary W. PaceDirector2025-07-3015,000$2.45
$36.75kBuy

1 of 1

CRDF insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when CRDF insiders and whales buy or sell their stock.

CRDF Shareholders

What type of owners hold Cardiff Oncology Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Robert Merrill Hunter7.41%5,065,004$7.85MInsider
Blackrock Inc5.82%3,981,387$6.17MInstitution
Ra Capital Management LP4.81%3,290,000$5.10MInsider
Gary W. Pace4.57%3,124,113$4.84MInsider
Bridger Management LLC4.34%2,968,115$4.60MInsider
Vanguard Capital Management LLC4.18%2,855,966$4.43MInstitution
Laurion Capital Management LP3.87%2,646,738$4.10MInstitution
Pfizer Inc3.53%2,411,575$3.74MInstitution
Acorn Capital Advisors LLC2.58%1,762,084$2.73MInstitution
Geode Capital Management LLC2.34%1,599,663$2.48MInstitution

1 of 3

CRDF vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
CRDF35.96%25.65%Net Buying
RANI34.48%32.99%Net Selling
VANI3.40%96.60%Net BuyingNet Buying
COYA34.67%9.20%Net Buying
VRCA14.80%85.20%Net Buying

Cardiff Oncology Stock Ownership FAQ

Who owns Cardiff Oncology?

Cardiff Oncology (NASDAQ: CRDF) is owned by 35.96% institutional shareholders, 25.65% Cardiff Oncology insiders, and 38.39% retail investors. Robert Merrill Hunter is the largest individual Cardiff Oncology shareholder, owning 5.07M shares representing 7.41% of the company. Robert Merrill Hunter's Cardiff Oncology shares are currently valued at $7.60M.

If you're new to stock investing, here's how to buy Cardiff Oncology stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.